KWAI MUNG CHIN: Open Payments
NPI 1366927980 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,345 in 231 payments from 45 companies in 2025. Trend: 2023 $3,120 · 2024 $4,099 · 2025 $5,345
Food & beverage: $4,605Education: $740
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $597 |
| Janssen Biotech, Inc. | 17 | $402 |
| Daiichi Sankyo Inc. | 13 | $396 |
| Merck Sharp & Dohme LLC | 14 | $260 |
| Novartis Pharmaceuticals Corporation | 14 | $260 |
| Incyte Corporation | 10 | $256 |
| AstraZeneca Pharmaceuticals LP | 12 | $234 |
| Gilead Sciences, Inc. | 2 | $227 |
| Lilly USA, LLC | 6 | $201 |
| SEAGEN INC. | 2 | $198 |
Products named: ENHERTU, VENCLEXTA, DARZALEX, KEYTRUDA, Trodelvy, OPDIVO, SARCLISA, TEVIMBRA.
Industry payments across MO — which companies pay providers there.
